NS
AXSM icon

NBC Securities’s Axsome Therapeutics AXSM Stock Holding History

NBC Securities’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$303K Sell
1,793
-642
-26% -$111K 0.02% 695
2025
Q4 		$445K Sell
2,435
-235
-9% -$32.8K 0.03% 540
2025
Q3 		$324K Buy
2,670
+60
+2% +$6.76K 0.02% 657
2025
Q2 		$272K Buy
2,610
+2,337
+856% +$247K 0.02% 719
2025
Q1 		$31K Buy
+273
New +$31.1K ﹤0.01% 1311
2024
Q4 		– Sell
-333
Closed -$29K – 1316
2024
Q3 		$29K Hold
333
– – ﹤0.01% 1351
2024
Q2 		$26K Hold
333
– – ﹤0.01% 1351
2024
Q1 		$26K Hold
333
– – ﹤0.01% 1360
2023
Q4 		$26K Hold
333
– – ﹤0.01% 1359
2023
Q3 		$23K Buy
+333
New +$24.9K ﹤0.01% 1389

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NBC Securities's AXSM Position: Q1 2026 in Review

NBC Securities reduced its Axsome Therapeutics (AXSM) stake by 26% in Q1 2026, selling an estimated $111K and leaving 1,793 shares worth $303K. The position accounts for 0.02% of the portfolio, ranked #695.

NBC Securities first reported a position in AXSM in Q3 2023 and has held it in 10 quarters since. The position peaked at $445K in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • NBC Securities held 1,793 shares of Axsome Therapeutics worth $303K as of Q1 2026.
  • NBC Securities sold 642 Axsome Therapeutics shares in Q1 2026, an estimated $111K.
  • Axsome Therapeutics made up 0.02% of NBC Securities's portfolio in Q1 2026, its #695 holding.
  • NBC Securities first reported a position in Axsome Therapeutics in Q3 2023 and has held it in 10 quarters since.
  • NBC Securities's Axsome Therapeutics position peaked at $445K in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on NBC Securities's 13F filing for Q1 2026, filed 14 Apr 2026.